Schaeffer's Top Stock Picks for '25

Penny Stock Surging on General Motors Sale

General Motors plans to put $700 million into Ohio facilities

Managing Editor
May 8, 2019 at 3:17 PM
facebook X logo linkedin


Stocks have made an unexpected turnaround this afternoon, following confirmation out of the White House that China is ready to make a trade deal. Also making moves this afternoon are Cincinnati-based Workhorse Group Inc (NASDAQ:WKHS), tobacco name Philip Morris International Inc. (NYSE:PM), and biopharma Protagonist Therapeutics Inc (NASDAQ:PTGX). Below, we will dive into what is moving the shares of WKHS, PM, and PTGX.

Workhorse Stock Surges on GM Announcement

Workhorse shares are surging this afternoon, the penny stock last seen up 134%, at $1.97. The lift comes just after President Donald Trump announced General Motors (GM) will be selling its Lordstown, Ohio, manufacturing shop to Workhorse. Upon approval from the United Auto Workers (UAW) union, GM will sell the factory and invest $700 million in three other Ohio locations. WKHS is now just shy of a 150% year-to-date lead. Meanwhile, the lone analyst covering Workhorse stock carries a "buy" recommendation.

Philip Morris Sinks as Walmart Raises Minimum Age

Cigarette giant Philip Morris is moving lower, down 0.5%, at $83.94, after Walmart (WMT) said it plans to raise the minimum age on tobacco sales to 21 with intent to curb the number of sales made to minors. In recent weeks PM has done little on the charts, testing support atop the 200-day moving average.

Coming into today options traders were optimistic, with data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) showing PM with a 10-day call/put volume ratio of 1.99, in the 75th percentile of its annual range. In other terms, calls have been bought over puts at a faster-than-usual clip during the past two weeks.

PTGX Lands $25 Milestone Payment

Protagonist Therapeutics is near the top of the Nasdaq today, after the biopharma received a $25 million payment advance from Janssen as part of their collaboration for PTG-200. At last check, PTGX is trading up 12.7% at $10.12.

The security has had a decent year, up 51% year-to-date, and is just over a month off its March 25 annual peak of $14.36. Plus, four of the five analysts following Protagonist Therapeutics stock sport "buy" or better recommendations.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));